IQV - NEW YORK STOCK EXCHANGE, INC.
Industry: Life Sciences Tools & Services
Market Cap: 26.5 B
IPO Date: May 9, 2013
Country: US
Currency: USD
Shares Outstanding: 176.3 M
5/9/2025
IQVIA reports strong Q1 earnings with $3.83B revenue & raised guidance.
Source: SeekingAlpha
5/7/2025
RESEARCH TRIANGLE PARK, N.C., May 07, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Annual Health Care Conference on Tuesday, May 13, 2025, at 5:20 p.m. ET (2:20 p.m. local PT).
Source: Yahoo
5/7/2025
IQVIA Holdings Inc. stock outperforms competitors on strong trading day
Source: MarketWatch
5/7/2025
IQVIA Holdings Inc (IQV) reports robust Q1 results with significant growth in Technology and Analytics Solutions, despite challenges in the R&D sector.
Source: Yahoo
5/7/2025
Q1 2025 IQVIA Holdings Inc Earnings Call
Source: Yahoo
5/7/2025
The headline numbers for IQVIA (IQV) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Source: Yahoo
5/6/2025
IQVIA Holdings (NYSE:IQV) recently announced its first-quarter earnings report, revealing a modest increase in sales but a decline in both net income and earnings per share compared to the previous year. The company also revised its full-year revenue guidance upward due to favorable currency exchange rates. Over the last week, IQV's share price climbed 1.45%, reflecting a somewhat positive response to these developments. Meanwhile, the broader market saw mixed sentiments as the S&P 500 ended...
Source: Yahoo
5/6/2025
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors
Source: MarketWatch
5/6/2025
IQV's top line in the first quarter of 2025 benefits from the Research and Development, and Technology and Analytics segments.
Source: Yahoo
5/6/2025
IQVIA Holdings Inc. (NYSE:IQV) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ETCompany ParticipantsKerri Joseph - Senior Vice President, Investor...
Source: SeekingAlpha
5/6/2025
Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 2.5% year on year to $3.83 billion. The company’s full-year revenue guidance of $16.2 billion at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $2.70 per share was 2.6% above analysts’ consensus estimates.
Source: Yahoo
5/6/2025
IQVIA (IQV) delivered earnings and revenue surprises of 2.66% and 1.55%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Source: Yahoo
5/6/2025
On a per-share basis, the Durham, North Carolina-based company said it had net income of $1.40. Earnings, adjusted for one-time gains and costs, came to $2.70 per share. The results surpassed Wall Street expectations.
Source: Yahoo
5/6/2025
RESEARCH TRIANGLE PARK, N.C., May 06, 2025--IQVIA Holdings Inc. ("IQVIA") (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended March 31, 2025.
Source: Yahoo
5/6/2025
Contract research firm IQVIA Holdingsbeat Wall Street estimates for first-quarter profit onTuesday, helped by better-than-expected demand for its drugresearch and development services. ...
Source: Finnhub
5/5/2025
Clinical research company IQVIA (NYSE: IQV) will be reporting earnings tomorrow before the bell. Here’s what to expect.
Source: Yahoo
5/5/2025
While clinical trial funding was up, deal-making was down, and new uncertainties are coming into the picture.
Source: Yahoo
5/1/2025
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors
Source: MarketWatch
5/1/2025
Growth across the R&DS and TAS segments is anticipated to have boosted IQV's top line in the first quarter of 2025.
Source: Yahoo
5/1/2025
Evaluate the expected performance of IQVIA (IQV) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Source: Yahoo